Comparison of laboratory-based and non-laboratory-based WHO cardiovascular disease risk charts: a population-based study

F Rezaei, M Seif, A Gandomkar, MR Fattahi… - Journal of Translational …, 2022 - Springer
Background Determining the risk of Cardiovascular Disease (CVD) is a necessity for timely
preventive interventions in high-risk groups. However, laboratory testing may be impractical …

Agreement between laboratory-based and non-laboratory-based Framingham risk score in Southern Iran

F Rezaei, M Seif, A Gandomkar, MR Fattahi… - Scientific reports, 2021 - nature.com
The Framingham 10-year cardiovascular disease risk is measured by laboratory-based and
non-laboratory-based models. This study aimed to determine the agreement between these …

Laboratory-based and office-based Globorisk scores to predict 10-year risk of cardiovascular diseases among Iranians: results from the Fasa PERSIAN cohort

L Jahangiry, A Dehghan, M Farjam, D Aune… - BMC medical research …, 2022 - Springer
Background Globorisk is a novel risk prediction model for predicting cardiovascular disease
(CVD). Globorisk is a country-specific risk prediction model that determines CVD risk for all …

Implementing and evaluating community health worker-led cardiovascular disease risk screening intervention in sub-Saharan Africa communities: A participatory …

K Okop, P Delobelle, EV Lambert, H Getachew… - International journal of …, 2022 - mdpi.com
The increasing burden of non-communicable diseases (NCDs), particularly cardiovascular
diseases (CVD) in low-and middle-income countries (LMICs) poses a considerable threat to …

A comparison of laboratory-based and office-based Framingham risk scores to predict 10-year risk of cardiovascular diseases: a population-based study

A Dehghan, S Ahmadnia Motlagh, R Khezri… - Journal of Translational …, 2023 - Springer
Abstract Background Two versions of Framingham's 10-year risk score are defined for
cardiovascular diseases, namely laboratory-based and office-based models. The former is …

Community health worker-led cardiovascular disease risk screening and referral for care and further management in rural and urban communities in Rwanda

JB Niyibizi, S Ntawuyirushintege… - International Journal of …, 2023 - mdpi.com
Cardiovascular disease (CVD) is a global health issue. Low-and middle-income countries
(LMICs) are facing early CVD-related morbidity. Early diagnosis and treatment are an …

[PDF][PDF] Calibration et discrimination du score de Framingham simplifié pour la prédiction du risque de maladie coronarienne dans une cohorte canadienne

J Garcon - 2023 - corpus.ulaval.ca
Résumé Introduction: Le score de Framingham est l'outil de prédiction du risque
cardiovasculaire recommandé par la Société Canadienne de Cardiologie. Aucune étude …